Antibacterial non-glycosidase activity of invertebrate destabilase-lysozyme and of its helical amphipathic peptides
Basic science published in Chemotherapy (2006)
Abstract
BACKGROUND: Since bactericidal properties of some lysozymes are independent of their glycosidase activity, we have investigated this phenomenon for destabilase-lysozyme (DL) from medicinal leech (Hirudo medicinalis). METHODS: Glycosidase activity was determined on Micrococcus luteus, non-enzymatic antibacterial activity of heat-treated DL and of synthetic peptides alpha1, alpha2 and alpha3 (fragments of its primary structure) on M. luteus, Escherichia coli, Bacillus brevis and Streptomyces chrysomallus. RESULTS: Glycosidase activity disappeared after the heating of native DL at 100 degrees C for 40 min. Antibacterial activity of heat-treated DL for M. luteus MDMSU128 and MDMSU140 expressed as minimal inhibitory concentration was 9.8.10(-8) and 12.10(-8) M, respectively, and to E. coli MDMSU52 11.10(-8) M. Antibacterial activity of synthetic peptide alpha1 for M. luteus MDMSU128 and for E. coli MDMSU52 was 8.3.10(-5) and 4.9.10(-5) M, respectively. CONCLUSION: DL is the first invertebrate lysozyme with combined enzymatic and non-enzymatic antibacterial action.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
Heat-treated destabilase retains antibacterial activity (MIC 9.8-12x10^-8 M) against M. luteus and E. coli even with glycosidase function abolished.
Por qué esto importa para la hirudoterapia
Este estudio investigó las propiedades antibacterianas de la desestabilasa-lisozima (DL) de la sanguijuela medicinal (Hirudo medicinalis), examinando específicamente su acción antibacteriana no enzimática y no glucosidásica. Es altamente relevante para el secretoma de la sanguijuela, al demostrar que la DL tratada por calor y los péptidos sintéticos derivados de su estructura conservan una potente actividad antibacteriana frente a patógenos como Micrococcus luteus y Escherichia coli. Esto revela que las moléculas derivadas de la sanguijuela poseen un mecanismo de defensa dual enzimático y no enzimático. No obstante, el alcance se limita a pruebas in vitro de sensibilidad microbiana con péptidos aislados o sintéticos de la sanguijuela, sin aportar datos sobre la eficacia de estos compuestos en modelos animales vivos ni en la hirudoterapia clínica.
Citación
Antibacterial non-glycosidase activity of invertebrate destabilase-lysozyme and of its helical amphipathic peptides.
Zavalova LL et al. · Chemotherapy, 2006
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026